This study is looking at how well the Aveir DR Leadless Pacemaker System works and its long-term health effects compared to a traditional dual-chamber pacemaker. Researchers will use existing health information from Medicare patients who have received either the Aveir DR Leadless Pacemaker or a standard dual-chamber pacemaker. The study aims to understand the rate of device-related complications within 30 days and how long patients survive after two years. You could be included if you are a Medicare beneficiary who received either of these pacemakers on or after the study's start date. This study uses real-world data, so you won't need to do anything extra.

Study design

This is an observational study that will look at health data from approximately 2,812 Medicare beneficiaries. It compares patients who received the Aveir DR Leadless Pacemaker to those who received a dual-chamber transvenous pacemaker.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will track acute device-related complications for 30 days and patient survival for two years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.